Advertisement
Advertisement

WST

WST logo

West Pharmaceutical Services, Inc.

230.88
USD
Sponsored
-6.63
-2.79%
Feb 03, 15:59 UTC -5
Closed
exchange

After-Market

230.97

+0.09
+0.04%

WST Earnings Reports

Positive Surprise Ratio

WST beat 34 of 39 last estimates.

87%

Next Report

Date of Next Report
Feb 12, 2026
Estimate for Q4 25 (Revenue/ EPS)
$802.32M
/
$1.85
Implied change from Q3 25 (Revenue/ EPS)
-0.28%
/
-5.61%
Implied change from Q4 24 (Revenue/ EPS)
+7.15%
/
+1.65%

West Pharmaceutical Services, Inc. earnings per share and revenue

On Oct 23, 2025, WST reported earnings of 1.96 USD per share (EPS) for Q3 25, beating the estimate of 1.69 USD, resulting in a 15.40% surprise. Revenue reached 804.60 million, compared to an expected 795.81 million, with a 1.10% difference. The market reacted with a +10.92% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 analysts forecast an EPS of 1.85 USD, with revenue projected to reach 802.32 million USD, implying an decrease of -5.61% EPS, and decrease of -0.28% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
CONMED Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$1.34
Actual
$1.43
Surprise
+5.94%
logo
Pro-Dex Inc New
Report Date
Jan 29, 2026 For Q2 26
Estimate
$0.60
Actual
$0.66
Surprise
+9.67%
FAQ
For Q3 2025, West Pharmaceutical Services, Inc. reported EPS of $1.96, beating estimates by 15.4%, and revenue of $804.60M, 1.1% above expectations.
The stock price moved up 10.92%, changed from $277.00 before the earnings release to $307.25 the day after.
The next earning report is scheduled for Feb 12, 2026.
Based on 16 analysts, West Pharmaceutical Services, Inc. is expected to report EPS of $1.85 and revenue of $802.32M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement